Setit, Baby Boy .
HRN: 26-60-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/10/2025
02/16/2025
IV
35 G
Q24
PSNB (PROM X 24 Hours)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes